Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_2afec86507fc41d4fd24a6693763f876 |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2800-20 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-6893 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-395 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-3955 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-395 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-68 |
filingDate |
2017-06-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_95e1d0744fd04d70d1b44ed8cdacc49e http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_93e5f99503211b84a7362e21907037b4 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8a35d74ba73fde5bd33c64d7fd740219 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_49347163911c4638cd017a831001d024 |
publicationDate |
2018-01-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
KR-20180007669-A |
titleOfInvention |
Composition comprising ITAC inhibitor |
abstract |
This specification describes a composition for the prevention or treatment of alleviation of vitiligo or alveoli comprising an interferon-inducible T-cell alpha chemoattractant (ITAC) inhibitor. The composition inhibits the action of ITAC to inhibit melanogenesis cell migration and exhibit a hypochromogenesis effect. In addition, the composition can inhibit the ITAC function and exhibit a preventive or curative effect on vitiligo or vitiligo metastasis. |
priorityDate |
2016-07-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |